$1.4 Billion for Alzheimer’s Research Supported by US Senate Appropriations Bill

$1.4 Billion for Alzheimer’s Research Supported by US Senate Appropriations Bill
The U.S. Senate Appropriations Committee  has forwarded a draft bill that could deliver nearly $1.4 billion in federal funds to Alzheimer’s disease (AD) research in 2017. In all health concerns related to the proposed bi-partisan bill, lawmakers recommend $34 billion - a $2 billion increase over fiscal year 2016 - to the National Institute of Health for research in precision medicine, Alzheimer’s disease, mapping of the human brain, and other diseases, according to a June 7 appropriations committee press release. The recommendation could land the largest-ever increase for Alzheimer's disease research funding at the NIH for the second consecutive year. The initiative, led in the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies by Roy Blunt (R-Mo.) and Patty Murray (D-Wash.), trails a $350 million year-over-year bump and reinforces the leaders’ commitments to Alzheimer's disease and dementia. The bill’s proposed funding aligns with overwhelming demands from Alzheimer's disease advocacy groups nationwide. UsAgainstAlzheimer’s (UsA2) pushed especially hard throughout 2016 for lawmakers to increase funding. In January, UsA2 sent a letter to the Office of Management and Budget and then carried out a sign-on letter to the appropriation committee in support advocacy initiatives.  The letter was signed by 30 Senators urging the appropriations sub-committee toward the additional funding. UsA2 and other groups have feverishly supported the momentum
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *